Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 8—August 2026
Letter
Doxycycline Resistance and 16S rRNA Mutations in Treponema pallidum
Suggested citation for this article
To the Editor: We read with interest but also concern the article by Long et al. (1) describing putative doxycycline resistance–associated variants of the Treponema pallidum ribosomal RNA 16S gene. Determining if T. pallidum can become resistant to doxycycline is urgent, given its use for both prevention (i.e., doxy-PEP) and treatment of syphilis, especially amid ongoing shortages of benzathine penicillin G.
As the groups that generated most of the sequencing data reanalyzed in Long et al. (1), our analyses were unable to replicate the primary finding of a heterozygous G966T 16S mutation (Escherichia coli numbering) in 9 samples. Using standard pathogen genomics methods (Figure), we did not find the variant in any reanalyzed sample at an allele frequency exceeding background technical noise.
Of note, >98% of publicly available T. pallidum genomes were generated from clinical specimens by metagenomic sequencing using hybrid capture probes. That method retains conserved non–T. pallidum DNA, such as ribosomal operons from other bacteria, in the sample (2,3), and can introduce errors when merging fragmented DNA reads into consensus sequences. Such artifacts may be incorporated into consensus T. pallidum genomes available from public resources such as pubMLST (https://pubmlst.org) or GenBank and misinterpreted as real mutations. Although Long et al. (1) reported filtering for reads arising from Treponema, we and others have shown the necessity of more stringent methods, such as competitive mapping versus related ribosomal sequences (2) or requiring near-identity to known T. pallidum rRNA sequences (4), to avoid inadvertent reporting errors.
The development of doxycycline resistance by T. pallidum could have devastating consequences for the control of syphilis and is being closely monitored by clinicians and scientists. We are encouraged by increasing genomic surveillance of T. pallidum, providing a mechanism for early detection of the emergence of resistance-associated variants.
References
- Long GS, Neale M, Braukmann T, Tran V, Singh N, Allen V, et al. Genomic analysis of doxycycline resistance–associated 16S rRNA mutations in Treponema pallidum subspecies pallidum. Emerg Infect Dis. 2026;32:242–5. DOIPubMedGoogle Scholar
- Beale MA, Marks M, Sahi SK, Tantalo LC, Nori AV, French P, et al. Genomic epidemiology of syphilis reveals independent emergence of macrolide resistance across multiple circulating lineages. Nat Commun. 2019;10:3255. DOIPubMedGoogle Scholar
- Chen W, Šmajs D, Hu Y, Ke W, Pospíšilová P, Hawley KL, et al. Analysis of Treponema pallidum strains from China using improved methods for whole-genome sequencing from primary syphilis chancres. J Infect Dis. 2021;223:848–53. DOIPubMedGoogle Scholar
- Lieberman NAP, Lin MJ, Xie H, Shrestha L, Nguyen T, Huang ML, et al. Treponema pallidum genome sequencing from six continents reveals variability in vaccine candidate genes and dominance of Nichols clade strains in Madagascar. PLoS Negl Trop Dis. 2021;15:
e0010063 . DOIPubMedGoogle Scholar
Figure
Suggested citation for this article: Beale MA, Marks M, Luetkemeyer A, Celum C, Golden MR, Giacani L, et al. Doxycycline resistance and 16S rRNA mutations in Treponema pallidum. Emerg Infect Dis. 2026 Aug [date cited]. https://doi.org/10.3201/eid3208.260433
Original Publication Date: July 16, 2026
Related Links
Table of Contents – Volume 32, Number 8—August 2026
| EID Search Options |
|---|
|
|
|
|
|
|

Please use the form below to submit correspondence to the authors or contact them at the following address:
Nicole Lieberman, University of Washington, 850 Republican St, Seattle, WA 98109, USA
Top